Flow cytometry (Figure 1G) showed that patients with ENKTL or DLBCL expressed higher levels of PD‐1 on CD4+ or CD8+T cells than healthy controls, as well as higher levels of PD‐L1 on CD4+T cells (Table 2, Figure 1A). This evidence concerns the gene CD4 and diffuse large B-cell lymphoma.